Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $110.0 million.

  • National Healthcare's Accumulated Expenses rose 2254.31% to $110.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.0 million, marking a year-over-year increase of 2254.31%. This contributed to the annual value of $92.7 million for FY2024, which is 1023.54% up from last year.
  • National Healthcare's Accumulated Expenses amounted to $110.0 million in Q3 2025, which was up 2254.31% from $111.6 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Accumulated Expenses peaked at $111.6 million during Q2 2025, and registered a low of $56.7 million during Q1 2023.
  • In the last 5 years, National Healthcare's Accumulated Expenses had a median value of $84.1 million in 2023 and averaged $83.4 million.
  • In the last 5 years, National Healthcare's Accumulated Expenses soared by 5236.73% in 2021 and then plummeted by 3204.18% in 2022.
  • Quarter analysis of 5 years shows National Healthcare's Accumulated Expenses stood at $106.7 million in 2021, then crashed by 32.04% to $72.5 million in 2022, then rose by 16.0% to $84.1 million in 2023, then rose by 10.24% to $92.7 million in 2024, then increased by 18.63% to $110.0 million in 2025.
  • Its Accumulated Expenses stands at $110.0 million for Q3 2025, versus $111.6 million for Q2 2025 and $96.3 million for Q1 2025.